Search Results - "Molina, Kimberly"

External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant by Rower, Joseph E., McKnite, Autumn, Hong, Borah, Daly, Kevin P., Hope, Kyle D., Cabrera, Antonio G., Molina, Kimberly M.

“…Study Objective The immunosuppressant tacrolimus is a first‐line agent to prevent graft rejection following pediatric heart transplant; however, it suffers…”
Get full text

Attitudes & practices surrounding pregnancy post heart transplant among pediatric providers by Collins, Megan M., Ou, Zhining, Millar, Morgan M., Kittleson, Michelle M., May, Lindsay J., Ploutz, Michelle S., Molina, Kimberly M., Hayes, Katherine G., Lal, Ashwin K.

“…Many pediatric heart transplant (HT) recipients reach adulthood and may be interested in family planning; there is little data regarding safety of pregnancy…”
Get full text

Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy by Kirmani, Sonya, Woodard, Pamela K., Shi, Ling, Hamza, Taye H., Canter, Charles E., Colan, Steven D., Pahl, Elfriede, Towbin, Jeffrey A., Webber, Steven A., Rossano, Joseph W., Everitt, Melanie D., Molina, Kimberly M., Kantor, Paul F., Jefferies, John L., Feingold, Brian, Addonizio, Linda J., Ware, Stephanie M., Chung, Wendy K., Ballweg, Jean A., Lee, Teresa M., Bansal, Neha, Razoky, Hiedy, Czachor, Jason, Lunze, Fatima I., Marcus, Edward, Commean, Paul, Wilkinson, James D., Lipshultz, Steven E.

“…Myocardial fibrosis, as diagnosed on cardiac magnetic resonance imaging (cMRI) by late gadolinium enhancement (LGE), is associated with adverse outcomes in…”
Get full text

Pulmonary artery resuscitation for isolated ductal origin of a pulmonary artery by Mery, Carlos M., MD, MPH, Molina, Kimberly M., MD, Krishnamurthy, Rajesh, MD, Fraser, Charles D., MD, Justino, Henri, MD

“…Objective Ductal origin of a pulmonary artery (DOPA) is commonly misdiagnosed as agenesis of a pulmonary artery (PA), which may result in inadequate treatment…”
Get full text

Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations by Kfoury, Abdallah G., MD, FACC, Miller, Dylan V., MD, Snow, Greg L., PhD, Afshar, Kia, MD, Stehlik, Josef, MD, Drakos, Stavros G., MD, PhD, Budge, Deborah, MD, Fang, James C., MD, Revelo, M. Patricia, MD, Alharethi, Rami A., MD, Gilbert, Edward M., MD, Caine, William T., MD, McKellar, Stephen, MD, Molina, Kimberly M., MD, Hammond, M. Elizabeth H., MD

“…Background Little is known about mixed cellular and antibody-mediated rejection (MR) in heart transplantation. It remains unclear whether cardiac MR has…”
Get full text

Fontan‐associated liver disease after heart transplant by Griffiths, Eric R., Lambert, Linda M., Ou, Zhining, Shaaban, Akraam, Rezvani, Maryam, Carlo, Waldemar F., Schumacher, Kurt R., DiPaola, Frank, O'Connor, Matthew J., Nandi, Deipanjan, Zangwill, Steven, McCulloch, Michael A., Friedland‐Little, Joshua M., West, Shawn C., Lee, Teresa M., Alejos, Juan C., Chen, Sharon, Molina, Kimberly M.

“…Background Fontan associated liver disease (FALD) potentially impacts Fontan patients undergoing heart transplant. This multi‐center study sought to identify…”
Get full text

Predictors of disease progression in pediatric dilated cardiomyopathy by Molina, Kimberly M, Shrader, Peter, Colan, Steven D, Mital, Seema, Margossian, Renee, Sleeper, Lynn A, Shirali, Girish, Barker, Piers, Canter, Charles E, Altmann, Karen, Radojewski, Elizabeth, Tierney, Elif Seda Selamet, Rychik, Jack, Tani, Lloyd Y

“…Despite medical advances, children with dilated cardiomyopathy (DCM) remain at high risk of death or need for cardiac transplantation. We sought to identify…”
Get full text

Implications of Left Ventricular Dysfunction at Presentation for Infants with Coarctation of the Aorta by McFarland, Carol A., Truong, Dongngan T., Pinto, Nelangi M., Minich, L. LuAnn, Burch, Phillip T., Eckhauser, Aaron W., Lal, Ashwin K., Molina, Kimberly M., Ou, Zhining, Presson, Angela P., May, Lindsay J.

“…Infants with aortic coarctation may present with left ventricular (LV) dysfunction which may complicate the postoperative course and lead to increased…”
Get full text

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study by Carlo, Waldemar F., MD, West, Shawn C., MD, MSc, McCulloch, Michael, MD, Naftel, David C., PhD, Pruitt, Elizabeth, MSPH, Kirklin, James K., MD, Hubbard, Meloneysa, MSN, Molina, Kimberly M., MD, Gajarski, Robert, MD, MHSA

“…Background Pulmonary blood flow during Stage 1 (Norwood) palliation for hypoplastic left heart syndrome (HLHS) is achieved via modified Blalock–Taussig shunt…”
Get full text

Heart Transplantation in Children With Down Syndrome by Godown, Justin, Fountain, Darlene, Bansal, Neha, Ameduri, Rebecca, Anderson, Susan, Beasley, Gary, Burstein, Danielle, Knecht, Kenneth, Molina, Kimberly, Pye, Sherry, Richmond, Marc, Spinner, Joseph A, Watanabe, Kae, West, Shawn, Reinhardt, Zdenka, Scheel, Janet, Urschel, Simon, Villa, Chet, Hollander, Seth A

“…Background Children with Down syndrome (DS) have a high risk of cardiac disease that may prompt consideration for heart transplantation (HTx). However,…”
Get full text

Parvovirus B19 Myocarditis Causes Significant Morbidity and Mortality in Children by Molina, Kimberly M., Garcia, Xiomara, Denfield, Susan W., Fan, Yuxin, Morrow, William R., Towbin, Jeffrey A., Frazier, Elizabeth A., Nelson, David P.

“…Although parvovirus B19 (PVB19) currently is the most common cause of viral myocarditis, limited pediatric data exist. Whereas other viruses infect…”
Get full text

ISHLT Pathology Antibody Mediated Rejection Score (pAMR) Correlates with Increased Risk of Cardiovascular Mortality: A Retrospective Validation Analysis by Hammond, M.E.H., M.D, Revelo, M.P., M.D, Miller, D.V., M.D, Snow, G.L., Ph.D, Budge, D., M.D, Stehlik, J., M.D, Molina, K.M., M.D, Selzman, C.H., M.D, Drakos, S.G., M.D. Ph.D, Alharethi, R.A., M.D, Nativi, J., M.D, Reid, B.B., M.D, Kfoury, A.G., M.D

“…Background Antibody mediated rejection (AMR) in cardiac transplant recipients is a serious form of rejection with adverse patient outcomes. The ISHLT has…”
Get full text

Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant by Everitt, Melanie D., MD, Hammond, M. Elizabeth H., MD, Snow, Gregory L., PhD, Stehlik, Josef, MD, Revelo, Monica P., MD, Miller, Dylan V., MD, Kaza, Aditya K., MD, Budge, Deborah, MD, Alharethi, Rami, MD, Molina, Kimberly M., MD, Kfoury, Abdallah G., MD

“…Background There is greater awareness of the pathologic features and clinical implications of antibody-mediated rejection (AMR) after heart transplantation…”
Get full text

Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy by Friedberg, Mark K, Margossian, Renee, Lu, Minmin, Mercer-Rosa, Laura, Henderson, Heather T, Nutting, Arni, Friedman, Kevin, Molina, Kimberly M, Altmann, Karen, Canter, Charles, Sleeper, Lynn A, Colan, Steven D

“…Systolic and diastolic function affect dilated cardiomyopathy (DCM) outcomes. However, systolic-diastolic coupling, as a distinct characteristic, may itself…”
Get full text

Yield of Cardiac Magnetic Resonance Imaging as an Adjunct to Echocardiography in Young Infants With Congenital Heart Disease by Johnson, Joyce T., Molina, Kimberly M., McFadden, Molly, Minich, L. LuAnn, Menon, Shaji C.

“…Echocardiography provides adequate preoperative imaging for most young infants with congenital heart disease (CHD). When anatomic details require further…”
Get full text

Cardiac biomarkers in pediatric cardiomyopathy: Study design and recruitment results from the Pediatric Cardiomyopathy Registry by Everitt, Melanie D., Wilkinson, James D., Shi, Ling, Towbin, Jeffrey A., Colan, Steven D., Kantor, Paul F., Canter, Charles E., Webber, Steven A., Hsu, Daphne T., Pahl, Elfriede, Addonizio, Linda J., Dodd, Debra A., Jefferies, John L., Rossano, Joseph W., Feingold, Brian, Ware, Stephanie M., Lee, Teresa M., Godown, Justin, Simpson, Kathleen E., Sleeper, Lynn A., Czachor, Jason D., Razoky, Hiedy, Hill, Ashley, Westphal, Joslyn, Molina, Kimberly M., Lipshultz, Steven E.

“…Cardiomyopathies are a rare cause of pediatric heart disease, but they are one of the leading causes of heart failure admissions, sudden death, and need for…”
Get full text

Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model by Rower, Joseph E, Stockmann, Chris, Linakis, Matthew W, Kumar, Shaun S, Liu, Xiaoxi, Korgenski, E Kent, Sherwin, Catherine M T, Molina, Kimberly M

“…ObjectiveImmunosuppressant therapy plays a pivotal role in transplant success and longevity. Tacrolimus, a primary immunosuppressive agent, is well known to…”
Get full text

Determinación de la auto-eficacia y el disfrute hacia la actividad física de los infantes que asisten al nivel de transición de escuelas en el Valle Central en tiempos de pandemia by Álvarez Bogantes, Carlos, Villalobos Víquez, Grettel Pamela, Molina Viales, Kimberly, Vargas Villalobos, Laura

“…La agudización del sobrepeso y la obesidad en niños de edad escolar en tiempos de pandemia representan un problema de salud pública. Lo que hace necesario que…”
Get full text

Abstract 14448: Graft Loss and Rejection Following COVID in Pediatric Heart Transplantation - A Pediatric Heart Transplant Society (PHTS) Propensity Matched Analysis by Spinner, Joseph, Conway, Jennifer, bocchini, claire, Cantor, Ryan S, Koehl, Devin, Kirklin, James K, Wright, Lydia, Molina, Kimberly, Shaw, Fawwaz, Villa, Chet, West, Shawn C

“…Abstract only Introduction: While short-term outcomes following COVID among pediatric heart transplant (HT) recipients have been described, graft outcomes…”
Get full text

Impact of tacrolimus variability on pediatric heart transplant outcomes by Sirota, Megan, Heyrend, Caroline, Ou, Zhining, Masotti, Susan, Griffiths, Eric, Molina, Kimberly

“…Background Tacrolimus is a narrow therapeutic index drug, requiring consistent levels to maximize transplant success while reducing adverse effects. Elevated…”
Get full text